This combination product contains two substances: tenofovir disoproxil (ATC code: J05A F07) and emtricitabine (ATC code: J05A F09). Both of them are safety classified as Probably not porphyrinogenic (PNP). The classification of the combination is therefore safety classified as Probably not porphyrinogenic (PNP). For more details please refer to the monographs of the two substances.

Uneventful use reported in 1 patient with acute intermittent porphyria.